Navigation Links
Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Date:8/27/2007

EDISON, N.J., Aug. 27 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") and Ipca Laboratories Ltd. ("Ipca") announced today that they have entered in to a strategic alliance for the development, supply and marketing of generic pharmaceutical products for the U.S. prescription drug market. Under the Agreement, Ipca shall develop and register selected products for U.S. ANDA submission and Heritage retains sales and marketing rights to such products. The parties shall share net profits from the sales proceeds post-launch.

Commenting on the Agreement, Heritage President & CEO, Jeffrey Glazer, stated, "Our agreement with Ipca represents yet another important strategic partnership with an emerging, low cost developer and supplier of active ingredients and finished goods. These types of agreements enable Heritage to leverage our business model of strategic outsourcing to obtain a "virtually vertical" supply chain of quality generic products as we continue to expand our product offerings."

Heritage Pharmaceuticals Inc. is an emerging generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage launched its U.S. label in 2006 and currently markets 3 products over 10 SKU's. The Company will continue to introduce its acquired multi-source generic product line during 2007-08 following its tradition of premier quality, value and service in generics.

Ipca Laboratories Ltd. is a fast growing fully integrated pharmaceutical company based in Mumbai, India engaged in the manufacturing and marketing of a range of pharmaceuticals with a thrust on international business. Ipca exports its Active Pharmaceutical Ingredients and Finished Dosages to over 110 countries across the globe, which contributed about 53% of the Company's total global income of $227mm in the financial year 2006-07. It has a strong focus on international business in the developed markets like Europe and North America.


'/>"/>
SOURCE Heritage Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NanoRite Innovation Center opens with small science, big promise
2. UW-Madison to receive $125M for bioenergy research center
3. WARF enters licensing agreements for stem cell products
4. Internet-enabled niche markets take center stage
5. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
6. TomoTherapy opens technical training center
7. Stem cell and regenerative medicine center to aid education and commerce
8. Mega-Metro Center may go beyond Chicago and Wisconsin
9. Software company enters health space with RFID solutions on hold
10. Former Fiserv exec to enter Business Hall of Fame
11. Berbee to expand at New Venture Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/31/2019)... ... December 31, 2019 , ... At this year's SLAS ... will be broadly focused on 3D cell culture , advanced imaging ... cell culture assays for assessing steatosis , inflammation and fibrosis as ...
(Date:12/27/2019)... ... December 27, 2019 , ... Leak Detection Associates (LDA), the ... Biotechnology, Medical Device and Food Packaging Industries is excited to celebrate the completion ... CLJ Holdings in February, 2019, a comprehensive and aggressive reorganization plan was implemented ...
(Date:12/23/2019)... ... December 23, 2019 , ... ... systems for the Pharmaceutical, Biotechnology and Medical Device Industries, is excited to announce ... Parenteral Drug Association (PDA) Container Closure Integrity Testing Basic Training Course . ...
(Date:12/18/2019)... ... December 17, 2019 , ... Philadelphia IP law ... that it has hired Dr. Alia Orbin, Ph.D., J.D., an experienced registered patent ... preparation, filing and prosecution of patent applications related to pharmaceutical sciences, organic and ...
Breaking Biology Technology:
(Date:1/7/2020)... ... January 07, 2020 , ... Lifecycle Biotechnologies ... just part numbers like what can be found in most catalogs, but rather, ... that is all linked to the impact it has on the global life ...
(Date:12/30/2019)... , ... December 30, 2019 , ... It’s been quite ... has seen its highest sales in 2019, having hosted a multitude of team-building events ... all visited the company’s La Jolla-based venue, and the company has worked hard to ...
(Date:12/18/2019)... (PRWEB) , ... December 17, 2019 , ... ... the pharmaceutical, biotech, medical device, and diagnostics industries, has named Pharmafusion LLC as ... an impressive year for the company and its founder/CEO Jonathan Retano. Earlier in ...
Breaking Biology News(10 mins):